News
LVTX
1.740
0.00%
0.000
Weekly Report: what happened at LVTX last week (1117-1121)?
Weekly Report · 11/24/2025 09:01
LAVA Therapeutics Delists from Nasdaq and Changes Leadership
TipRanks · 11/21/2025 13:31
LAVA Therapeutics Announces Voluntary Delisting from Nasdaq
Reuters · 11/21/2025 13:01
XOMA Royalty Closes Acquisition of LAVA Therapeutics
Reuters · 11/21/2025 12:45
NASDAQ TRADE HALT <LVTX.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 11/21/2025 00:50
Weekly Report: what happened at LVTX last week (1110-1114)?
Weekly Report · 11/17/2025 09:01
LAVA Therapeutics to Delist from Nasdaq Amid Acquisition
TipRanks · 11/13/2025 14:03
LAVA intents to delist from Nasdaq
Seeking Alpha · 11/13/2025 13:51
Lava Therapeutics announces intent to delist from Nasdaq
TipRanks · 11/13/2025 12:45
LAVA THERAPEUTICS NV - SUBMITS NOTICE TO NASDAQ TO VOLUNTARILY DELIST SHARES
Reuters · 11/13/2025 12:30
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
Barchart · 11/13/2025 06:30
BiotechBroyalty aggregator XOMA reports Q3 net income of $14.1 mln
Reuters · 11/12/2025 12:41
REFILE-Biotech royalty aggregator XOMA reports Q3 net income of $14.1 mln
Reuters · 11/12/2025 12:41
XOMA Royalty reports Q3 revenue of $9.4 million and year-to-date revenue of $38.4 million
Reuters · 11/12/2025 12:30
LAVA Therapeutics Extends Share Tender Deadline for XOMA Offer to November 12, 2025
Reuters · 11/10/2025 21:14
Weekly Report: what happened at LVTX last week (1103-1107)?
Weekly Report · 11/10/2025 09:01
LAVA Therapeutics Approves Merger with New Topco B.V.
TipRanks · 11/07/2025 21:33
LAVA Therapeutics NV Held Extraordinary General Meeting
Reuters · 11/07/2025 21:09
Weekly Report: what happened at LVTX last week (1027-1031)?
Weekly Report · 11/03/2025 09:01
Weekly Report: what happened at LVTX last week (1020-1024)?
Weekly Report · 10/27/2025 09:01
More
Webull provides a variety of real-time LVTX stock news. You can receive the latest news about LAVA Therapeutics N.V. through multiple platforms. This information may help you make smarter investment decisions.
About LVTX
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.